GleamWall
中文EN

RFL Rafael Holdings, Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 1713863 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.7%
TTM net income YoY-58.3%
TTM EPS YoY44.2%
Revenue 3-yr CAGR46.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,821.2%
Net margin-3,390.7%
FCF margin—
EBITDA margin-3,797.8%

Returns

ROE-36.9%
ROA-30.1%
ROIC (approx.)-61.5%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets13.3%
Debt / equity0.00x
Current ratio2.35x
Interest coverage-100.29x

Cash quality & payout

Operating cash flow / net income1.01x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-07-31FY20252025-07-31
Income statement
Revenue$874,000$917,000
R&D expense$24.33M$12.82M
SG&A expense$9.70M$13.78M
Operating income-$33.41M-$29.16M
Interest expense$333,000$658,000
Pretax income-$27.97M-$33.20M
Income tax-$13,000-$2.55M
Net income-$29.64M-$30.52M
EBITDA-$33.20M-$28.87M
EPS (basic)-0.58-1.04
EPS (diluted)-0.58-1.04
Weighted avg. shares (diluted)51.39M29.42M
Balance sheet
Cash & equivalents$22.10M$52.77M
Receivables$444,000$627,000
Inventory$377,000$281,000
Current assets$25.82M$56.71M
PP&E, net$1.50M$1.60M
Goodwill$19.94M$19.94M
Intangibles$863,000$994,000
Total assets$83.06M$114.11M
Current liabilities$10.99M$11.60M
Total liabilities$11.09M$15.74M
Shareholders' equity$66.31M$94.39M
Cash flow statement
Operating cash flow-$29.99M-$18.92M
Capital expenditure$3,000$4,000
Free cash flow-$29.99M-$18.93M
Investing cash flow-$676,000$44.03M
Financing cash flow-$116,000$24.83M
Depreciation & amortization$204,000$288,000
Stock-based compensation$1.39M$2.12M

Free plan shows the latest 2 periods; Pro shows all 11 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.